Research ArticlePsoriatic Arthritis
Open Access
PGA×BSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol
Jessica A. Walsh, Terri Arledge, Tommi Nurminen, Luke Peterson and Jeffrey Stark
The Journal of Rheumatology July 2018, 45 (7) 922-928; DOI: https://doi.org/10.3899/jrheum.170244
Jessica A. Walsh
From the Division of Rheumatology, University of Utah, Salt Lake City, Utah; UCB Pharma, Raleigh, North Carolina; UCB Pharma, Smyrna, Georgia, USA; UCB Pharma, Monheim,
Germany.
Terri Arledge
Tommi Nurminen
Luke Peterson
REFERENCES
- 1.↵
- Gladman D,
- Antoni C,
- Mease P,
- Clegg D,
- Nash P
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- Youn SW,
- Choi CW,
- Kim BR,
- Chae JB
- 7.↵
- 8.↵
- 9.↵
- Bonifati C,
- Berardesca E
- 10.↵
- 11.↵
- Merola JF,
- Gottlieb AB
- 12.↵
- Duffin KC,
- Papp KA,
- Bagel J,
- Levi E,
- Chen R,
- Gottlieb AB
- 13.↵
- Mease P,
- Fleischmann R,
- Deodhar AA,
- Wollenhaupt J,
- Khraishi M,
- Kielar D,
- et al.
- 14.↵
- 15.↵
- van der Heijde D,
- Fleischmann R,
- Wollenhaupt J,
- Deodhar A,
- Kielar D,
- Woltering F,
- et al.
- 16.↵
- Chiesa Fuxench ZC,
- Callis Duffin K,
- Siegel M,
- Van Voorhees AS,
- Gelfand JM
In this issue
The Journal of Rheumatology
Vol. 45, Issue 7
1 Jul 2018
PGA×BSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol
Jessica A. Walsh, Terri Arledge, Tommi Nurminen, Luke Peterson, Jeffrey Stark
The Journal of Rheumatology Jul 2018, 45 (7) 922-928; DOI: 10.3899/jrheum.170244